Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Parkinson’s Disease Foundation Marks Tenth Year of People with Parkinson’s Advisory Council

Patient Advisors Drive PDF Mission to Solve, Treat and End Parkinson’s

The Parkinson’s Disease Foundation® (PDF®) is pleased to mark the tenth year of its People with Parkinson’s Advisory Council and welcome five new members. Created in 2006, the council is made up of people living with Parkinson’s and care partners who drive PDF’s goals of ending the disease and improving the lives of those affected by it.

“As the PDF People with Parkinson’s Advisory Council marks a new decade, we renew our commitment to representing the community’s urgency for better treatments and a cure, and to guiding PDF toward the programs that best meet community needs,” said Daniel Novak, Ph.D., of Fort Worth, TX, who was recently elected Chair of the advisory council. “As a pioneer in patient engagement, PDF has long understood that an informed and empowered patient community is instrumental to ending this disease.”

Advisory council members guide PDF’s mission and priorities; identify and solve unmet needs; provide input on programs; and serve as liaisons to the community. The advisory council has helped to prompt some of PDF’s more important initiatives, including its Community Choice Research Awards, which seek feedback from the patient community on research; its patient education materials, including the popular Parkinson’s Disease Resource List and bi-monthly webinars; and its innovative patient advocacy programs, including the newly launched Women and PD Initiative and the PD SELF program.

The advisory council’s newest members represent a wide range of communities, professions and personal experiences. They include the following individuals:

Mary Bendelow, Ph.D., of Conifer, CO: a retired communications consultant who currently serves as a tour director for US and Canadian national parks.

Andrée Jannette of West Chester, PA: a freelance writer and photographer with more than 20 years of experience working in strategic traditional and digital communications.

Rebecca Miller, Ph.D., of New Haven, CT: a clinical psychologist, Director of Peer Support and Family Initiatives at Connecticut Mental Health Center and Assistant Professor at Yale School of Medicine, Department of Psychiatry.

Leslie Peters of Colorado Springs, CO: a health care coordinator, care partner to her husband who lives with Parkinson’s and former care partner to her late mother-in-law who lived with the disease.

Paul Rohrlich, Ph.D., of Falls Church, VA: a retired foreign service officer with more than 25 years of experience working as an economic, environment and science officer with the US Department of State.

“Over the past decade, PDF has benefitted from the guidance and wisdom of more than 40 members of this advisory council, who have helped us to better understand and address community needs and who have worked tirelessly to improve the lives of people with Parkinson’s,” said Robin Anthony Elliott, PDF President. “For PDF, these accomplishments are proof that engaging the patient community in our work is not only the right thing to do; it is also effective.”

About Parkinson's Disease
Parkinson's disease is a progressive neurological disorder that affects nearly one million people in the US. Although promising research is being conducted, there is currently no cure for Parkinson's disease.

Tuesday, May 24, 2016
Parkinson's Foundation Study Finds Gender Disparities in Caregiving, with Women at a Disadvantage
Monday, December 4, 2017

Largest Clinical Study Tracking Parkinson’s Patients Over Time Shows Women with Parkinson’s Have Fewer Caregiving Resources than Men with Parkinson’s

Parkinson’s Foundation Invests $60,000 to Develop Innovative Models of Patient Engagement
Wednesday, November 29, 2017

Six Awards Foster Patient-Driven Parkinson’s Research

Jesse Jackson Diagnosed with Parkinson's Disease
Friday, November 17, 2017

Rev. Jesse Jackson’s announcement today that he has been living with Parkinson’s Disease since 2015 further proves that receiving a diagnosis of Parkinson's is not a death sentence. There are many ways that people living with Parkinson's can control the symptoms of the disease with exercise and physical therapy to help maintain mobility and balance.

Update on Tozadenant Trial for Parkinson’s
Thursday, November 16, 2017

On 11/20/17, Acorda Therapeutics, Inc. announced that it is discontinuing the tozadenant clinical trial.  They concluded that they could not be confident that weekly white blood cell count screening would sufficiently ensure patient safety.

Parkinson’s Foundation Adds Marcia Mondavi Borger to Board of Directors
Tuesday, November 14, 2017

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Marcia Mondavi Borger to its Board of Directors.

Parkinson’s Foundation and Melvin Yahr International Parkinson’s Disease Foundation Announce Merger
Thursday, October 26, 2017

Parkinson’s Foundation Establishes ‘Dr. Melvin Yahr Research Award’ to Fund Neurology Fellows, Promote Leadership Diversity in Parkinson’s Research

Parkinson’s Foundation Welcomes Two New Board Members
Tuesday, October 24, 2017

Peter Goldman and Joshua Raskin Join Board of Directors

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Chicago entrepreneur Peter Goldman and New York financial analyst Joshua Raskin to its Board of Directors.

Parkinson's Foundation Unveils New Brand and Website
Thursday, October 19, 2017

NEW YORK and MIAMI /PRNewswire-USNewswire/ — The Parkinson's Foundation today announced the launch of its new brand and website following the recent merger of two legacy organizations – National Parkinson Foundation and Parkinson's Disease Foundation – as part of its mission to

FDA Approves Extended-Release Amantadine (GOCOVRI™) for Treatment of Dyskinesia
Friday, August 25, 2017

Statement from the Parkinson's Foundation Medical Director, Michael Okun, MD

Parkinson’s Foundation Announces $1.2 Million Investment to Advance Careers, Support Innovation of Early Career Parkinson’s Scientists
Tuesday, August 8, 2017

NEW YORK & MIAMI The Parkinson's Foundation is pleased to announce a $1.2 million investment in 27 career development and fellowship grants to support the work of promising early career scientists in the field of Parkinson's.

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.